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Crc is a post-transcriptional regulator in Pseudomonas aeruginosa
that modulates its metabolism, but also its susceptibility to
antibiotics and virulence. Most of P. aeruginosa virulence factors
are secreted or engulfed in vesicles. A Crc deﬁcient mutant was
created and the extracellular vesicles associated exoproteome and
the vesicle-free secretome was quantiﬁed using iTRAQ. Fifty
vesicles-associated proteins were more abundant and 14 less
abundant in the Crc-defective strain, whereas 37 were more
abundant and 17 less abundant in the vesicle-free secretome.
Different virulence determinants, such as ToxA, protease IV, azurin,
chitin-binding protein, PlcB and Hcp1, were less abundant in the
Crc-defective mutant. We also observed that the crc mutant
presented an impaired vesicle-associated secretion of quorum
sensing signal molecules and less cytotoxicity than its wild-type
strain, in agreement with the low secretion of proteins related to
virulence. Our results offer new insights into the mechanisms
by which Crc regulates P. aeruginosa virulence, through theier Inc. This is an open access article under the CC BY license
/j.jprot.2015.06.009
ez).
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J.A. Reales-Calderón et al. / Data in Brief 4 (2015) 450–453 451modulation of vesicle formation and secretion of both virulence
determinants and quorum sensing signals.
& 2015 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations tableSubject area Biology
More speciﬁc
subject areaMicrobiologyType of data Tables
How data was
acquiredProteomic analysis of extracellular vesicles (EVs) and vesicle-free secretome of Pseudomonas
aeruginosa PAO1 and FCP001 (Crc-defective strain)Data format Analyzed
Experimental factors Secretome extraction, extracellular vesicles isolation and vesicle-free secretome concentration
Experimental
featuresExtracellular vesicles and vesicle free secretome were obtained from Pseudomonas aeruginosa PAO1
(wild-type strain) and FCP001 (crc-defective mutant), proteins were solubilized and digested.
Peptides were labeled with iTRAQ reagents. Proteins were identiﬁed and quantiﬁed by nano-LC ESI-
MSMSData source location Madrid, Spain
Data accessibility Data are available with this paperValue of the data The exoproteome of P. aeruginosa is analyzed using iTRAQ technology
 The vesicle-associated proteome of P. aeruginosa is analyzed using iTRAQ technology.
 Crc modulates the secretion of virulence factors and generation of vesicles in P. aeruginosa.1. Data, experimental design, materials and methods
The data show the lists of proteins identiﬁed and quantiﬁed in Extracellular Vesicles (EVs) and in
the vesicle-free secretome fraction of the wild-type strain Pseudomonas aeruginosa PAO1 and its
isogenic crc-deffective derivative FCP001. The analysis was performed by nano-LC ESI-MSMS analysis
using a nano-liquid chromatography system coupled to high speed Triple TOF 5600 mass
spectrometer with a duo spray ionization source. The proteins were quantiﬁed and processed using
Analysts TF 1.5.1 Software (AB SCIEX). Table 1 contains a list of 1058 proteins identiﬁed in the P.
aeruginosa vesicle-free secretome and Table 2 contains 643 quantiﬁed proteins with 2 or more
peptides in the same fraction. Table 3 contains a list of 839 proteins identiﬁed in the P. aeruginosa EVs
fraction. Table 4 list the 489 proteins with 2 or more peptides identiﬁed in EVs sample. Of these, 37
proteins were more abundant and 16 were less abundant in the vesicle-free secretome and 50
proteins were more abundant and 14 less abundant in the EVs of the FCP001 mutant defective in crc
than they were in the control PAO001 parental strain [1]. All mass spectrometry proteomics data have
been deposited to the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org)
via the PRIDE partner repository [2] using MIAPE Extractor v3.7.2, with the dataset identiﬁer
PXD000687 and DOI 10.6019/PXD000687.
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Three biological replicates of P. aeruginosa PAO001 and FCP001 were obtained from mid-
exponential growth phase cultures (OD600 of 0.6). Extracellular vesicles were concentrated using a
Centricon Plus-70 ﬁlter (4100 kDa) and pelleted by ultracentrifuged at 100,000 g for 1 h at 4 1C.
The supernatants were collected, mixed with the ﬂowthrough o100 kDa and concentrated using a
10 kDa cut-off ﬁlter to obtain the vesicle-free secretome. Proteins were solubilised in 0.5 M
Triethylammonium bicarbonate (TEAB) buffer supplemented with a protease inhibitor cocktail.3. Quantitative proteomic analysis
3.1. Sample preparation
Vesicle and vesicle-free secretomes were treated and analyzed independently. Samples were
precipitated with methanol/chloroform and resuspended in 0.5 M Triethylammonium bicarbonate
(TEAB). 30 mg of protein from each condition were used for the trypsin digestion. Proteins were
denatured in 6 M guanidine hydrochloride/100 mM HEPES, pH 7.5, reduced in 50 mM Tris (2-
carboxyethyl) phosphine (TCEP, AB SCIEX), pH 8.0, at 60 1C for 60 min, and 200 mM cysteine-blocking
reagent (methyl methanethiosulfonate (MMTS, Pierce) were added for 10 min at room temperature.
Samples were digested by adding 3 ml (1 mg/ml) sequence grade-modiﬁed trypsin to each sample in a
ratio 1/10 (w/w). The samples were then incubated at 37 1C overnight on a shaker and evaporated to
dryness.
3.2. iTRAQ labeling
Secretome and vesicle-free secretome digested samples were labeled at room temperature for 2 h
with a half-unit of iTRAQ Reagent Multi-plex kit (AB SCIEX, Foster City, CA, USA) previously
reconstituted with 80 μl of 70% ethanol/50 mM TEAB. The iTRAQ labeling was performed separately in
a 2-plex design for each condition. In the ﬁrst labeling (iTRAQ1), tags 114 and 115 were used for the
vesicle-free secretome samples. In the second labeling (iTRAQ2), tags 116 and 117 were used for
vesicle samples. After that, samples were combined and labeling reaction was stopped by adding
100 ml of 50% ACN, followed by evaporation of the samples in a vacuum concentrator.
The digested, labeled and pooled peptide mixtures were desalted using a Sep-PAK C18 Cartridge
(Waters), following manufacture indications; the cleaned tryptic peptides were evaporated to dryness
and stored at 20 1C for further analysis.
3.3. Liquid chromatography and mass spectrometer analysis
A 2.5 mg aliquot of each peptide mixture was subjected to 2D-nano-LC ESI-MSMS analysis using a
nano-liquid chromatography system coupled to high speed Triple TOF 5600 mass spectrometer with a
duo spray ionization source. The analytical column used was a silica-based reversed phase column C18
ChromXP 75 mm15 cm, 3 mm particle size and 120 Å pore. The trap column was a C18 ChromXP, 3 mm
particle diameter, 120 Å pore size, switched on-line with the analytical column. The loading pump
delivered a solution of 0.1% formic acid in water at 2 ml/min. The nano-pump provided a ﬂow-rate of
300 nl/min and was operated under gradient elution conditions, using 0.1% formic acid in water as mobile
phase A, and 0.1% formic acid in acetonitrile as mobile phase B. Gradient elution was performed according
the following scheme: isocratic conditions of 98% A: 2% B for 1 min, a linear increase to 30% B in 120 min, a
linear increase to 40% B in 10 min, a linear increase to 90% B in 5 min, isocratic conditions of 90% B for
5 min and return to initial conditions in 2 min. Injection volume was 5 ml.
Data acquisition was performed with a Triple TOF 5600 System. Data was acquired using an ionspray
voltage ﬂoating (ISVF) 2800 V, curtain gas (CUR) 20, interface heater temperature (IHT) 150, ion source
gas 1 (GS1) 20, declustering potential (DP) 85 V. All data were acquired using information-dependent
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mass range of 350–1250 Da was followed by 15 MS/MS scans of 250 ms in the mass range of 100–1800
(total cycle time: 4.04 s). Switching criteria were set to ions greater than mass to charge ratio (m/z) 350
and smaller thanm/z 1250 with charge state of 2–5 and an abundance threshold of more than 90 counts
(cps). Former target ions were excluded for 20 s. IDA rolling collision energy (CE) parameters script was
used for automatically controlling the CE.
All mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium
(http://proteomecentral.proteomexchange.org) via the PRIDE partner repository [2] using MIAPE
Extractor v3.7.2, with the dataset identiﬁer PXD000687 and DOI 10.6019/PXD000687.
3.4. Data analysis
MS and MS/MS data obtained for pooled samples were processed using Analysts TF 1.5.1 Software.
Raw data ﬁle conversion tools generated mgf ﬁles which were also searched against the P. aeruginosa
(PAO001) database, containing 5563 protein sequences and their corresponding reversed entries
using the Mascot Server v. 2.3.02. Search parameters were set as follows: enzyme, trypsin; allowed
missed cleavages, 1; ﬁxed modiﬁcations, iTRAQ 4-plex (N-term and K) and beta-methylthiolation of
cysteine; variable modiﬁcations, oxidation of methionine. Peptide mass tolerance was set to
725 ppm for precursors and 0.05 Da for fragment masses. Frequency distribution histograms of
protein ratios were obtained into Excel 2010. Log2 peptide ratios followed a normal distribution that
was ﬁtted using least squares regression. Mean and standard deviation values derived from the
Gaussian ﬁt were used to calculate p-values and quantiﬁcation of False Discovery Rates (FDR).The
conﬁdence interval for protein identiﬁcation was set to Z95% (po0.05) and only peptides with an
individual ion score above the 1% False Discovery Rates (FDR) threshold were considered correctly
identiﬁed. Only proteins having at least two quantitated peptides were considered in the quantitation.
Changes among the different samples were considered as relevant when the ratio between PAO001
and FCP001 were 71 (Log2) in, at least two of the three biological replicates.Appendix A. Supplementary Information
Supplementary data associated with this article can be found in the online version at http://dx.doi.
org/10.1016/j.dib.2015.07.002.References
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